In 2015, large-scale genetic and functional studies brought us closer to understanding the underlying aetiology of polycystic ovary syndrome (PCOS), implicating genes involved in modulation of gonadotropin and neuroendocrine action, ovarian androgen biosynthesis and possibly insulin action, providing clues to the evolutionary path and potential evolutionary advantages of PCOS.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review
Journal of Endocrinological Investigation Open Access 15 March 2024
-
Identification of a novel ESR1 mutation in a Chinese PCOS woman with estrogen insensitivity in IVF treatment
Reproductive Biology and Endocrinology Open Access 18 November 2022
-
Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study
BMC Endocrine Disorders Open Access 03 December 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
29 January 2016
In the original published article, the second bullet point in the Key advances should have read: "Genetic variation in epidermal growth factor receptor genes affects susceptibility to PCOS5". This error has been corrected in the HTML and PDF versions of the article.
References
Zawadski, J. K. & Dunaif, A. in Polycystic Ovay Syndrome (eds Dunaif, A. et al.) 377–384 (Blackwell Scientific, 1992).
Hayes, M. G. et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat. Commun. 6, 7502 (2015).
Chen, Z. J. et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat. Genet. 43, 55–59 (2011).
Shi, Y. et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 44, 1020–1025 (2012).
Day, F. R. et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat. Commun. 6, 8464 (2015).
Jones, M. R. et al. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet. 11, e1005455 (2015).
McAllister, J. M. et al. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype. Proc. Natl Acad. Sci. USA 111, E1519–E1527 (2014).
Goodarzi, M. O. et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J. Med. Genet. 49, 90–95 (2012).
Hardy, J. & Singleton, A. Genomewide association studies and human disease. N. Engl. J. Med. 360, 1759–1768 (2009).
Vink, J. M., Sadrzadeh, S., Lambalk, C. B. & Boomsma, D. I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab. 91, 2100–2104 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.A. has acted as a consultant for Global PET and KinDex Pharmaceuticals.
Rights and permissions
About this article
Cite this article
Azziz, R. New insights into the genetics of polycystic ovary syndrome. Nat Rev Endocrinol 12, 74–75 (2016). https://doi.org/10.1038/nrendo.2015.230
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2015.230
This article is cited by
-
Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review
Journal of Endocrinological Investigation (2024)
-
The effects of low-level laser therapy on polycystic ovarian syndrome in rats: three different dosages
Lasers in Medical Science (2023)
-
Identification of a novel ESR1 mutation in a Chinese PCOS woman with estrogen insensitivity in IVF treatment
Reproductive Biology and Endocrinology (2022)
-
Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study
BMC Endocrine Disorders (2021)
-
The role of miRNAs in polycystic ovary syndrome with insulin resistance
Journal of Assisted Reproduction and Genetics (2021)